Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 31Terminated 11Unknown 3Withdrawn 2Active not recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Sleep Wake Disorders 1Ovarian Neoplasms 1Fatigue 1Depression 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT00903214 2013-04-29

Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer

Barbara Ann Karmanos Cancer Institute

Phase 1 Withdrawn
Breast

Breast Neoplasms

NCT00460200 2012-10-04

Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer

Jonsson Comprehensive Cancer Center

Withdrawn
Gynecologic

Carcinoma, Ovarian Epithelial, Depression, Fatigue, Ovarian Neoplasms, Sleep Wake Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡